REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $651,583 | +15.1% | 53,939 | +0.8% | 0.00% | – |
| Q2 2023 | $566,041 | +6.9% | 53,501 | -0.6% | 0.00% | – |
| Q1 2023 | $529,382 | -66.3% | 53,799 | -49.6% | 0.00% | – |
| Q4 2022 | $1,568,968 | +141.8% | 106,660 | +99.5% | 0.00% | – |
| Q3 2022 | $649,000 | -12.2% | 53,475 | +1.2% | 0.00% | – |
| Q2 2022 | $739,000 | -35.4% | 52,827 | -34.3% | 0.00% | – |
| Q1 2022 | $1,144,000 | -13.1% | 80,350 | +28.8% | 0.00% | – |
| Q4 2021 | $1,316,000 | +88.5% | 62,394 | +134.7% | 0.00% | – |
| Q3 2021 | $698,000 | +48.5% | 26,589 | +76.3% | 0.00% | – |
| Q2 2021 | $470,000 | +127.1% | 15,083 | +149.9% | 0.00% | – |
| Q4 2020 | $207,000 | – | 6,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |